Security key
70261F202
Pasithea Therapeutics Corp. - Common Stock (KTTA)
CUSIP: 70261F202
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 25,016,593
- Total 13F shares
- 300,344
- Share change
- +221,640
- Total reported value
- $216,624
- Price per share
- $0.72
- Number of holders
- 10
- Value change
- +$151,923
- Number of buys
- 7
- Number of sells
- 2
Report period
Q2 2025
Institutions
10
Top holders
10
KTTA full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Pasithea Therapeutics Corp. SEC filings
Pasithea Therapeutics Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 70261F202
Recent filing periods:
Top shareholders of KTTA - Pasithea Therapeutics Corp. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
317,863
|
$537,188 | $0 | 06 May 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
5%
|
142,082
|
$240,119 | +$14,019 | 31 Mar 2025 | |
| Orca Capital AG |
13D/G
|
— |
4.9%
|
362,857
|
$613,228 | -$14,002 | 07 May 2025 | |
| Lawrence Steinman |
13D/G
|
— |
3.1%
|
83,858
|
$141,720 | $0 | 01 Mar 2025 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.21%
|
53,547
|
$66,398 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
13,706
|
$17,818 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
4,337
|
$5,638 | — | 31 Mar 2025 | |
| Hurley Capital, LLC |
13F
|
Company |
0.01%
|
3,689
|
$4,796 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,267
|
$4,247 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
150
|
$195 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
8
|
$10 | — | 31 Mar 2025 | |
| PD Joint Holdings, LLC Series 2016-A |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,608,696
|
$1,124,348 | — | 22 Oct 2022 | |
| Eric Shahinian |
3/4/5
|
Member of 10% owner group |
—
class O/S missing
|
1,788,415
|
$770,807 | — | 28 Sep 2022 | |
| Israel Maxx Abramowitz |
3/4/5
|
Not a 10% owner |
—
class O/S missing
|
1,051,575
|
$453,229 | — | 14 Sep 2021 | |
| Dean Lazer |
3/4/5
|
Not a 10% owner |
—
class O/S missing
|
902,600
|
$389,021 | — | 14 Sep 2021 | |
| Eric Lazer |
3/4/5
|
Not a 10% owner |
—
class O/S missing
|
902,600
|
$389,021 | — | 14 Sep 2021 | |
| David Delaney |
3/4/5
|
Member of 10% owner group |
—
class O/S missing
|
227,521
|
$98,062 | — | 17 Oct 2022 | |
| Avi Geller |
3/4/5
|
Member of 10% owner group |
—
class O/S missing
|
54,644
|
$23,552 | — | 19 Aug 2022 | |
| Dr. Yassine Bendiabdallah |
3/4/5
|
Chief Operating Officer, Director |
—
class O/S missing
|
300,000
|
$129,300 | — | 14 Sep 2021 | |
| Kepos Capital LP |
13F
|
Company |
—
class O/S missing
|
334,600
|
$6,000 | — | 31 Mar 2025 | |
| Warberg Asset Management LLC |
13F
|
Company |
—
class O/S missing
|
100,000
|
$2,030 | — | 31 Mar 2025 | |
| Marex Group plc |
13F
|
Company |
—
class O/S missing
|
25,000
|
$460 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
class O/S missing
|
10,579
|
$193 | — | 31 Mar 2025 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
71
|
$1 | — | 31 Mar 2025 | |
| Graeme Martin Currie |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
5,938
|
— | — | 01 Mar 2024 |
Institutional Holders of Pasithea Therapeutics Corp. - Common Stock (KTTA) as of Q2 2025
As of 30 Jun 2025,
Pasithea Therapeutics Corp. - Common Stock (KTTA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
300,344 shares.
The largest 10 holders included
AdvisorShares Investments LLC, CITADEL ADVISORS LLC, UBS Group AG, LPL Financial LLC, Hurley Capital, LLC, RAYMOND JAMES FINANCIAL INC, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., JPMORGAN CHASE & CO, and BANK OF AMERICA CORP /DE/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
7
Q2 2025 holders
10
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.